Funding Opportunities
2025¨C2026 Seed Projects
Introduction
In 2025¨C26, the Convergent Science Cancer Consortium for Immune Cell Engineering, funded by the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Cancer Research Program (PRCRP), will support up to four seed projects that will contribute to the career development of junior faculty members and postdoctoral trainees at MD Anderson, the University of Houston and Vanderbilt University Medical Center, as well as other institutions outside this consortium. The Seed Project Program focuses on identifying, recruiting and mentoring both lab-based scientists and physician-scientists interested in the translational development of novel adoptive cell therapy approaches against hematological malignancies and solid tumors with an unmet clinical need. This goal will be accomplished by a scientific research plan, educational opportunities, and a defined individualized mentoring program that enables awardees to become active members of our Convergent Science Cancer Consortium.
Eligibility
Candidates for this award must:
- have an M.D. and/or a Ph.D.
- be a junior faculty member at assistant professor or instructor level or a trainee (postdoctoral fellow or clinical fellow) who has a commitment for an institutional faculty position at an assistant professor or instructor level
Application
The following must be included:
- Face Page
- Research Plan (5-page limit) to include:
- Specific Aims (1 page)
- Career Development Plan (1 page)
- Research Strategy (3 pages) to include:
- Significance
- Innovation
- Relevance to military health
- Approach
- Bibliography and References Cited (no page limit)
- Protection of Human Subjects (no page limit) following the NIH guidelines regarding Human Subjects
- Vertebrate Animals (no page limit) following the NIH guidelines regarding Vertebrate Animals
- Facilities and Other Resources (no page limit)
- Budget & Budget Justification: The application must include a detailed budget for one year and a budget justification using the . Each award consists of a maximum of $50,000 for one year, with consideration of a second year of funding based on achieving progress toward established milestones.
- Biographical Sketch (5-page maximum, each) in either DoD- or NIH-specified format for applicant and mentor(s)
- Letters: One letter of support from each mentor(s)
Due September 5, 2025
5 p.m. (CT)
Format: The required font is 11-point Arial. Margins must be at least 0.50 inches on all sides.
Submission information
Submit your application (as a single attachement) by email to Alison Woo, consortium administrator, at AWoo@MDAnderson.org no later than September 5, 2025, at 5 p.m. Central Time.
Key dates
Request for Applications Release Date: August 1, 2025
Full Application Due: September 5, 2025, 5 p.m. CT
Anticipated Award Notification: October 3, 2025
Inquiries
Alison Woo, M.S.
Consortium Administrator
MD Anderson Cancer Center
713-563-3432
awoo@mdanderson.org
Kyung Hee Chang, Ph.D.
Consortium Administrator
MD Anderson Cancer Center
kchang6@mdanderson.org